Key result
Elevated cTnI and cTnT in acute heart failure were associated with increased 6-month mortality, but were not independent risk markers on multivariable analysis.
Why the study?
Do elevated cardiac troponin I and T levels predict 6-month mortality in non-ACS acute heart failure patients?
Cohort (n=364)
Yes
Do elevated cardiac troponin I and T levels predict 6-month mortality in non-ACS acute heart failure patients?
While cardiac troponin elevations are common in non-ACS acute heart failure and associated with increased mortality, they do not serve as independent risk markers when adjusting for other factors like Cystatin C and NT-proBNP.
Answers are grounded in this paper and cite their sources.
Caution against troponin-guided risk stratification in acute HF; leaves open incremental prognostic value beyond NT-proBNP and cystatin C.
BACKGROUND: Elevated cardiac troponin (cTn) levels are relatively common in acute heart failure (AHF). AIMS: To evaluate the prevalence and prognostic significance of elevated cTnI and cTnT in AHF. METHODS: FINN-AKVA is a prospective, multicenter study in AHF. In this analysis, 364 non-ACS patients with measurements of cTnI and cTnT taken on admission and 48 h thereafter were analyzed. RESULTS: Of the 364 AHF patients, 51.1% had cTnI and 29.7% cTnT levels above the cut-off value. Six-month all-cause mortality was 18.7%. Both cTnI (OR 2.0, 95% CI 1.2-3.5, p=0.01) and cTnT (OR 2.6, 95% CI 1.5-4.4, p=0.0006) were associated with adverse outcome. The mortality risk was proportional to the magnitude of cTn release. On multivariable analysis, Cystatin C (OR 6.3, 95% CI 3.2-13, p<0.0001), logNT-proBNP (OR 1.4, 95% CI 1.0-1.8, p=0.03) and systolic blood pressure on admission (/10 mm Hg increase, OR 0.9, 95% CI 0.8-0.9, p=0.0004) were independent risk markers, whereas the troponins were not significantly associated with increased mortality. CONCLUSIONS: cTn elevations are frequent in AHF patients without ACS. cTnI is more often elevated than cTnT. Both cTnI and cTnT elevations are associated with increased mortality proportional to the degree elevation but they do not act as independent risk markers.
No takes yet. Share an insight, caveat, or question.
Ilva et al. (2008) conducted a cohort in Acute Heart Failure (n=364). Elevated cardiac troponin I and T vs. Normal cardiac troponin levels was evaluated on 6-month all-cause mortality (OR 2.0, 95% CI 1.2-3.5, p=0.01). Elevated cTnI and cTnT in acute heart failure were associated with increased 6-month mortality, but were not independent risk markers on multivariable analysis.
Synapse has enriched 10 related papers. Consider them for comparative context: